Abbott FreeStyle Libre 2 integrated continuous glucose monitoring system will now be available to US Medicare beneficiaries with diabetes, the company announced on 1 September.
Abbott said it has now secured partial or full reimbursement for its entire FreeStyle Libre portfolio in 37 countries, including Canada, France, Germany, Japan, the UK and the US.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?